Journal article
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States
Abstract
OBJECTIVES: The Inflation Reduction Act (IRA), enacted in 2022, brings substantial reforms to the US healthcare system, particularly regarding Medicare. A key aspect includes the introduction of Medicare price negotiation. The objective of this commentary is to explore the implications of the IRA for US pharmaceutical companies, with a specific focus on the role of real-world evidence (RWE) in the context of Medicare reforms.
METHODS: This …
Authors
Arora P; Gupta A; Mackay E; Heeg B; Thorlund K
Journal
Value in Health, Vol. 27, No. 8, pp. 999–1002
Publisher
Elsevier
Publication Date
August 2024
DOI
10.1016/j.jval.2024.04.007
ISSN
1098-3015